MICHELLE SONNIER: Open Payments
NPI 1427350446 · CANKTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 19 payments from 5 companies in 2025. Trend: 2023 $396 · 2024 $132 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $170 |
| Supernus Pharmaceuticals, Inc. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Amgen Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
Products named: Qelbree, QULIPTA, VRAYLAR, CAPLYTA, UBRELVY, OTEZLA, ZORYVE.
Industry payments across LA — which companies pay providers there.
